Contributor Page
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 4084000
Fax: +1 202 4084400
901 New York Avenue, NW
Washington, DC
United States
By Margaret Esquenet, Jonathan Uffelman
In this article, Finnegan attorneys Margaret Esquenet and Jonathan Uffelman discuss the case.
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
A listing of the Patent Quality Chats that occurred during 2018 can be found here.
By Amana Abdulwakeel
On June 15, 2018, FDA issued Guidance on Logical Observation Identifiers Names and Codes (LOINC) for in vitro diagnostic (IVD) tests.
By Fionnuala Richardson, Clare Cornell
From 14 January 2019 the long-awaited Trade Mark Directive (2015/2436) will take effect in the UK, reflecting the UK's continued effort to enhance harmonisation of trade mark law across the EU.
By Paula E. Miller, Shana Cyr
Happy New Year! In case you missed them, here are our five most popular posts from 2018. This has been an exciting year for the Finnegan IP FDA Blog ...
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The USPTO decided not to extend the Extended Missing Parts Pilot Program beyond January 2, 2019.
By Elizabeth Ferrill, Samhitha Muralidhar
Happy New Year! We thought we'd take a quick look back at our most popular posts from 2018.
By Morgan Smith, Margaret Esquenet
New Year's Day was a bit different this year. It brought something unseen for the past twenty years: the mass infusion of previously copyrighted works into the public domain
By Doris Hines, Luke McCammon, Jinwoo Kim
Protecting semiconductor device and fabrication process inventions can be challenging.
By Sanam Habib
Having said goodbye to 2018 a week ago, we thought we would take a look back at the most popular posts from the year.
By Adriana Burgy, John M Mulcahy
Even during a partial government shutdown, the USPTO provided us with a gift for the New Year!
By Daniel Klodowski, David Seastrunk, Michael R Galgano, Aaron Parker, Elliot C. Cook
For comparison, the cumulative average rate of instituted claims cancelled in IPR and CBM Final Written Decisions is about 75%.
By Caitlin E. O'Connell
The Automotive Body Parts Association ("ABPA") appeals from an Eastern District of Michigan decision granting summary judgment for Ford.
By Razi Safi, Samhitha Muralidhar
In Vivint Inc. v. Inc., No. 17-2218 (December 20, 2018), the Federal Circuit in a non-precedential opinion affirmed the Board's invalidation of some of Vivant's patent claims
By Megan L. Meyers
In Laerdal Medical Corp. v. International Trade Commission, No. 17-2445, the CAFC reversed the ITC's final determination that Laerdal failed to plead its trade dress infringement claims with adequate detail...
Contributor's Topics